Dose based on m² [General Sta­tis­tics]

posted by VK – Russia, 2013-07-17 18:17 (4105 d 12:35 ago) – Posting: # 11000
Views: 9,087

Dear Dr_Dan,

Thank you for the prompt reply. Please let me comment below:

❝ What do you mean by "We did regular calculations"?


We calculated PK parameters (Cmax, AUClast and Cmax/AUClast), correspodning 90% CIs and ANOVA (as required in Russia) for 100% of patients.

❝ If you had choosen

❝ 70% received 4x25mg

❝ 30% received either 3x25mg or 5x25mg

❝ Then 100% of the subjects could be evaluated.


This is our case. To shed more light on the design - 70% receieved 4*500mg, while 30% received either 3*500mg or 5*500 mg. Hence the only strength was 500, while the doses were different.

So the regulatory body experts tell us that we should use 70% for the calculation because the received one dose. That is why I looking for some kind of GL/textbook I could refer our experts.

Cheers,

VK

Complete thread:

UA Flag
Activity
 Admin contact
23,249 posts in 4,885 threads, 1,665 registered users;
67 visitors (0 registered, 67 guests [including 7 identified bots]).
Forum time: 06:53 CEST (Europe/Vienna)

I believe there is no philosophical high-road in science,
with epistemological signposts. No, we are in a jungle
and find our way by trial and error,
building our road behind us as we proceed.    Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5